Provided by Tiger Trade Technology Pte. Ltd.

Alnylam Pharmaceuticals

239.81
+3.801.61%
Volume:670.70K
Turnover:160.02M
Market Cap:32.00B
PE:42.68
High:240.67
Open:236.56
Low:235.41
Close:236.01
52wk High:495.55
52wk Low:197.81
Shares:133.43M
Float Shares:133.16M
Volume Ratio:0.50
T/O Rate:0.50%
Dividend:- -
Dividend Rate:- -
EPS(TTM):5.62
EPS(LYR):2.33
ROE:96.55%
ROA:12.34%
PB:23.63
PE(LYR):102.92

Loading ...

Alnylam (ALNY) Stock May Look Rich On Earnings Despite Weaker Price Action

Simply Wall St.
·
Yesterday

Alnylam to present new clinical data on ATTR, hypertension at ESC Congress

TIPRANKS
·
Aug 24

NASDAQ Top and Bottom Performing Stocks at About 02:45 P.m. EDT on 2026-08-21

Reuters
·
Aug 22

Movement Alert|Alnylam Pharmaceuticals Rises 5.75% in After-Hours Trading, Trading at $232.0

Market Focus
·
Aug 21

Lowered TTR Sales Outlook And Legal Probe Might Change The Case For Investing In Alnylam (ALNY)

Simply Wall St.
·
Aug 21

Movement Alert|Alnylam Pharmaceuticals Falls 5.07% in Regular Trading, Trading at $229.555

Market Focus
·
Aug 21

NASDAQ Top and Bottom Performing Stocks at About 11:01 A.m. EDT on 2026-08-20

Reuters
·
Aug 20

Movement Alert|Alnylam Pharmaceuticals Rises 5.06% in Regular Trading, Trading at $238.57

Market Focus
·
Aug 19

Alnylam Pharmaceuticals Shares up 5.2% After Bmo Initiates Coverage with Outperform Rating

THOMSON REUTERS
·
Aug 19

Alnylam Pharmaceuticals Initiated at Outperform by BMO Capital

Dow Jones
·
Aug 19

Alnylam Pharma (ALNY) Gets a Hold from Wells Fargo

TIPRANKS
·
Aug 14

U.S. Research Roundup-Cisco, Fox Corp, Target

Reuters
·
Aug 14

Alnylam Pharma (ALNY) Receives a Buy from Stifel Nicolaus

TIPRANKS
·
Aug 13

Is Alnylam’s Mixed 2026 Guidance Reset Altering The Investment Case For Alny (ALNY)?

Simply Wall St.
·
Aug 12

Movement Alert|Alnylam Pharmaceuticals Falls 5.04% in Regular Trading, Continued Pressure After Q2 Guidance Cut

Market Focus
·
Aug 07

Tenaya Therapeutics Q2 Net Loss Widens on Impairment Charge

Reuters
·
Aug 06

Tenaya Net Loss Widens to $43.39 Million in Q2 FY26; R&D Expenses Slip to $16.6 Million

Reuters
·
Aug 06

NASDAQ Top and Bottom Performing Stocks at About 11:01 A.m. EDT on 2026-08-05

Reuters
·
Aug 05

H.C. Wainwright Sticks to Its Buy Rating for Alnylam Pharma (ALNY)

TIPRANKS
·
Aug 04

Alnylam Pharmaceuticals is Maintained at Buy by HC Wainwright & Co.

Dow Jones
·
Aug 04